Clinical outocomes of nivolumab plus ipilimumab in metastatic renal cell carinoma

Taigo Kato,Kazutoshi Fujita,Akira Nagahara,Wataru Nakata, Kyousuke Matsuzaki,Koji Hatano,Atsunari Kawashima,Shingo Takada,Kensaku Nishimura,Masao Tsujihata,Tetsuya Takao,Yasutomo Nakai,Masashi Nakayama,Kazuo Nishimura, Motohide Uemura,Hirotsugu Uemura,Norio Nonomura

ANNALS OF ONCOLOGY（2023）

引用 0|浏览7

暂无评分

摘要

In metastatic renalcell carcinoma (mRCC), recent clinical trials have shown efficacy of first-line combination therapy, as evidenced by better clinical outcome over target therapy. However, there are insufficient real-world evidences in mRCC patients in Japan.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要